4.8 Review

The dual functional role of MicroRNA-18a (miR-18a) in cancer development

期刊

出版社

JOHN WILEY & SONS LTD
DOI: 10.1186/s40169-019-0250-9

关键词

MiR-18a; Biogenesis; Tumorigenesis; Oncogenesis; EMT; Clinical applications

资金

  1. National Natural Science Foundation of China [81772639, 81802475]
  2. Natural Science Foundation of Beijing [7192157]
  3. CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-001]
  4. Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2018PT32014, 2018PT32002]
  5. China Postdoctoral Science Foundation [198831]
  6. CAMS Innovation Fund for Medical Students [2017-1002-1-16]
  7. PUMC Youth Fund [2017320027]
  8. Fundamental Research Funds for the Central Universities [2017320027]

向作者/读者索取更多资源

The polycistronic miR-17-92 cluster is instrumental in physiological processes commonly dysregulated in cancer, such as proliferation, the cell cycle, apoptosis, and differentiation. MicroRNA-18a (miR-18a) is one of the most conserved and multifunctional miRNAs in the cluster and is frequently overexpressed in malignant tumors. Altered miR-18a expression has been found in various physiological and pathological processes, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), tumorigenesis, cancer invasion and metastasis. In this review, we summarized the molecular basis and regulatory targets of miR-18a in cancer development. Interestingly, miR-18a has a dual functional role in either promoting or inhibiting oncogenesis in different human cancers. The differential miRNA expression in cancers of the same organ at different stages or of various subtypes suggests that this dual function of miR-18a is independent of cancer type and may be attributed to the fundamental differences in tumorigenic mechanisms. Finally, we summarized the current clinical use of miR-18a and discussed its potential uses in cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据